Phenacetin.
D000082:Acetaminophen / Q000009:adverse effects; D000983:Antipyrine / Q000009:adverse effects; D003718:Denmark; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D007680:Kidney Neoplasms / Q000139:chemically induced; D007681:Kidney Papillary Necrosis / Q000139:chemically induced; D007880:Legislation, Drug; D010615:Phenacetin / Q000009:adverse effects*; D011704:Pyelonephritis / Q000139:chemically induced; D012459:Salicylates / Q000009:adverse effects; D019966:Substance-Related Disorders; D013548:Sweden; D013557:Switzerland; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
D012459:Salicylates; D000082:Acetaminophen; D010615:Phenacetin; D000983:Antipyrine